Table 5 |
||||||||||||
|
Sensitivity, specificity and predictive values of NashTest for the diagnosis of NASH |
||||||||||||
|
NashTest diagnosis |
Histological Diagnosis |
|||||||||||
|
|
||||||||||||
|
Training Group n = 160 |
Validation Group n = 97 |
All patients n = 257 |
||||||||||
|
|
||||||||||||
|
Se |
Sp |
PPV |
NPV |
Sensitivity |
Specificity |
PPV |
NPV |
Sensitivity |
Specificity |
PPV |
NPV |
|
|
|
||||||||||||
|
NASH |
11/28 39% |
122/132 92% |
11/21 52% Prevalence = 0.18 |
122/139 88% |
10/35 29% |
61/62 98% |
10/11 91% Prevalence = 0.36 |
61/86 71% |
21/63 33% |
183/194 94% |
21/32 66% Prevalence = 0.25 |
183/225 81% |
|
Borderline or NASH |
96/103 93% |
20/57 35% |
96/133 72% Prevalence = 0.64 |
20/27 74% |
44/56 79% |
29/41 71% |
44/56 79% Prevalence = 0.58 |
29/41 71% |
140/159 88% |
49/58 50% |
140/189 74% Prevalence = 0.62 |
49/68 72% |
|
|
||||||||||||
|
Poynard et al. BMC Gastroenterology 2006 6:34 doi:10.1186/1471-230X-6-34 |
||||||||||||
